23andMe gene diagnosis is not reliable?

Genetic detection of disease is a relatively in-depth health detection methods, through the molecular biology of human susceptibility gene detection and analysis, users can understand the state of the body and possible disease risks, follow up the corresponding disease prevention and health guidance.

One of the most typical examples of genetic testing is that the Hollywood goddess Angelina Jolie decided to undergo a preventative bilateral mastectomy when she learned that the family had a genetic defect and had a higher risk of breast and ovarian cancer. But genetic testing company 23andMe and Uber's fate is similar, the former was a year ago in the United States by the FDA (Food and Drug administration, the Drug Administration) stopped.

However, 23andMe has gone smoothly in the UK, and its testing mix (including saliva collection containers, container plugs, transparent bags, etc.) has been licensed by the Scientific Ethics Research Institute (about Committee), whether through public health (NHS) or private medical care, Can include British citizens in research and business.

According to Engadget, the UK has supported 23andMe because it has helped to some extent promote local development of the 100000 Genome Research Project (genomics England). Disease detection, labeling and prediction were done by sequencing 100,000 genes.

In the United States, the FDA still does not have access to the 23andMe restrictions, the reason is that disease detection has a certain risk, in case of detection errors, people because of the fear of breast cancer will be a mastectomy, people's health loss, who is responsible for this responsibility has become a problem to consider. Since it is a medical device, it must be regulated ...